CLEAR CELL SARCOMA OF SOFT TISSUE
Clinical trials for CLEAR CELL SARCOMA OF SOFT TISSUE explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL SARCOMA OF SOFT TISSUE trials appear
Sign up with your email to follow new studies for CLEAR CELL SARCOMA OF SOFT TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a drug called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to standard therapy. The drug works by blocking enzymes that help tumors grow and form blood vesse…
Matched conditions: CLEAR CELL SARCOMA OF SOFT TISSUE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New combo therapy aims to shrink sarcomas before surgery
Disease control OngoingThis study looks at whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before they are removed surgically. About 140 adults and children with newly diagnosed, high-risk sarcomas that can be operated on are participating. Th…
Matched conditions: CLEAR CELL SARCOMA OF SOFT TISSUE
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC